INS-GENERIC PRESCRIPTION DRUGS Senate SponsorsSen. Andy Manar-Melinda Bush 1/13/2021SenateSession Sine Die 215 ILCS 5/155.37Amends the Illinois Insurance Code. Provides that if a generic equivalent for a brand name drug is approved by the Food and Drug Administration, insurance companies with plans that provide coverage for prescription drugs through the use of a drug formulary that are amended, delivered, issued, or renewed in the State on or after January 1, 2021 shall immediately substitute the brand name drug with the generic equivalent or move the brand name drug to a formulary tier that reduces an enrollee's cost. Grants rulemaking authority to the Department of Insurance. Defines "brand name drug", "generic drug", and "formulary". Effective January 1, 2021. 2/14/2020SenateFiled with Secretary by Sen. Andy Manar 2/14/2020SenateFirst Reading 2/14/2020SenateReferred to Assignments 2/18/2020SenateAdded as Chief Co-Sponsor Sen. Melinda Bush 3/3/2020SenateAssigned to Insurance 3/18/2020SenateRule 2-10 Committee Deadline Established As April 2, 2020 3/25/2020SenateRule 2-10 Committee Deadline Established As April 24, 2020 3/25/2020SenateRule 2-10 Third Reading/Passage Deadline Established As May 7, 2020 4/12/2020SenatePursuant to Senate Rule 3-9(b) / Referred to Assignments 4/16/2020SenateRule 2-10 Committee Deadline Established As April 30, 2020 4/23/2020SenateRule 2-10 Committee Deadline Established As May 7, 2020 4/23/2020SenateRule 2-10 Third Reading/Passage Deadline Established As May 15, 2020 4/30/2020SenateRule 2-10 Committee Deadline Established As May 15, 2020 4/30/2020SenateRule 2-10 Third Reading/Passage Deadline Established As May 22, 2020 5/7/2020SenateRule 2-10 Committee Deadline Established As May 22, 2020 5/7/2020SenateRule 2-10 Third Reading/Passage Deadline Established As May 29, 2020 5/15/2020SenateRule 2-10 Committee/3rd Reading Deadline Established As May 31, 2020 1/13/2021SenateSession Sine Die